Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aethlon Medical

4.34
-0.0100-0.23%
Volume:26.68K
Turnover:115.36K
Market Cap:3.30M
PE:-0.06
High:4.49
Open:4.39
Low:4.16
Close:4.35
52wk High:84.40
52wk Low:4.02
Shares:761.20K
Float Shares:720.00K
Volume Ratio:0.68
T/O Rate:3.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-68.1067
EPS(LYR):-85.7749
ROE:-207.29%
ROA:-63.64%
PB:0.96
PE(LYR):-0.05

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
1 hour ago

Aethlon Medical Inc expected to post a loss of $3.66 a share - Earnings Preview

Reuters
·
Nov 08

Aethlon Medical Inc. to Report Fiscal Second Quarter Results

Reuters
·
Nov 07

Aethlon Medical Regains Nasdaq Compliance After Stock Surge

TIPRANKS
·
Nov 06

Aethlon Medical Inc - Regains Compliance With Nasdaq Minimum Bid Price - SEC Filing

THOMSON REUTERS
·
Nov 06

Aethlon Medical Faces Nasdaq Non-Compliance Notice

TIPRANKS
·
Oct 23

Aethlon Medical Faces Nasdaq Delisting After Failing Minimum Bid Price Requirement

Reuters
·
Oct 23

Aethlon Medical trading halted, news pending

TIPRANKS
·
Oct 18

Aethlon Medical Inc - Authorizes 1-for-10 Reverse Stock Split - SEC Filing

THOMSON REUTERS
·
Oct 16

Aethlon Medical Announces 1-for-10 Reverse Stock Split Effective October 16, 2025

Reuters
·
Oct 16

BRIEF-Aethlon Medical's Hemopurifier® Shows Changes In Extracellular Vesicles, Extracellular Micrornas, And T Cell Numbers In Australian Oncology Clinical Trial

Reuters
·
Oct 07

Aethlon Medical Announces Promising Early Data from Australian Clinical Trial of Hemopurifier® in Cancer Patients Resistant to Anti-PD-1 Therapy

Reuters
·
Oct 07

Aethlon Medical Announces New Share Structure Update

TIPRANKS
·
Sep 13

Aethlon Medical Inc. Announces $4.5 Million Public Offering of Common Stock and Warrants

Reuters
·
Sep 10

Aethlon Medical Inc. Announces $4.5 Million Public Offering of Common Stock and Warrants

Reuters
·
Sep 04

Aethlon Medical Announces Pricing of $4.5 Million Public Offering

THOMSON REUTERS
·
Sep 04

Aethlon Medical Inc. Unveils Presentation on Hemopurifier® Blood Purification Device and Its Potential in Oncology and Infectious Disease Treatment

Reuters
·
Sep 04

Aethlon Medical Inc. Announces New Hemopurifier® Patent Issuances for Long COVID and COVID-19-Associated Coagulopathy Treatment

Reuters
·
Sep 03

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long Covid and Covid-19-Associated Coagulopathy (Cac)

THOMSON REUTERS
·
Sep 03

Aethlon Medical Inc. Unveils Corporate Presentation Highlighting Hemopurifier® Blood Purification Device and Breakthrough Designations

Reuters
·
Aug 21